Kevin Ault, MD, FACOG, emphasizes that obstetric clinicians are patients' most trusted vaccine information source, making maternal COVID-19 counseling a high-value opportunity.
|Articles|June 24, 2020
Medicaid and CHIP providers: How to access the Provider Relief Fund
Author(s)Lindsey Carr, Editor
The U.S. Department of Health and Human Services (HHS) will distribute $15 billion to eligible Medicaid and Children’s Health Insurance Program (CHIP) providers.
Advertisement
To prepare physicians for this release, the Health Resources and Services Administration will host a live webinar tomorrow, Thursday 25, 2020 at 2 p.m. The webinar will guide physicians through the application process and discuss provider distribution.
To learn more about the Provider Relief Fund, visit the
Advertisement
Related to this article
ACOG strongly recommends COVID-19, RSV, and flu vaccines for pregnant patients ahead of the 2026–27 respiratory season.
A new Gallup survey found 51% of women in the United States reported negative healthcare experiences.
Hugh Taylor, MD, explains that imaging in endometriosis is best for ruling out other causes of pelvic pain and cannot exclude the diagnosis.
A new study links earlier menopause age to faster cognitive decline and earlier Alzheimer diagnosis.
The FDA office of Women's Health and Center for Drug Evaluation and Research and hosting a public workshop with a focus on testosterone use in menopausal women.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, weighs his own experience with pellet therapy against guideline evidence, then he and Maria Uloko, MD, close with candid advice for clinicians too afraid of hormones to start prescribing.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, and Maria Uloko, MD, walk through real-world dosing, cost workarounds, and the labs that actually matter for safety and efficacy.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Earlier menopause associated with less favorable functional, structural neurological outcomes
2
FDA holding public meeting on testosterone use in menopausal women
3
Off-label testosterone dosing, access, and lab monitoring in the US
4
Pellet therapy and practical advice for hesitant prescribers
5